Evidence method
Level · gp.fundamentals.capex_revenue_ratio
4.33% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
TNXP · Jun 30, 2026
Tonix Pharmaceuticals Holding Corp.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001999371-26-017452General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-311.89% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
577.88% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
94.81% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-314.05% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
143.36% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
16.66% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History7 statesHistory building
Period transition
What moved in the state?
- Previous
- 24.60%
- Current
- 4.33%
- Delta
- -20.27%
- Previous
- -615.27%
- Current
- -311.89%
- Delta
- 303.37%
- Previous
- 183.16%
- Current
- 577.88%
- Delta
- 394.72%
- Previous
- 77.06%
- Current
- 94.81%
- Delta
- 17.75%
- Previous
- -603.91%
- Current
- -314.05%
- Delta
- 289.86%
- Previous
- 264.80%
- Current
- 143.36%
- Delta
- -121.44%
- Previous
- 28.64%
- Current
- 16.66%
- Delta
- -11.99%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Pharmaceutical Preparations peers →Has State · Tonix Pharmaceuticals Holding Corp. →Transitioned To · TNXP Fundamental State →Transitioned To · TNXP CAPEX_INTENSITY_DECREASED →Transitioned To · TNXP CASH_GENERATION_INCREASED →Transitioned To · TNXP GROWTH_INCREASED →Transitioned To · TNXP MARGIN_INCREASED →Transitioned To · TNXP PROFITABILITY_INCREASED →Transitioned To · TNXP R_AND_D_INTENSITY_DECREASED →Transitioned To · TNXP SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.